Implementing shared decision-making: consider all the consequences
Elwyn, Frosch, Kobrin · 2016
공개 학술지 Implementation Science : IS 에 실린 총설 논문입니다(2016년). CC BY 4.0 으로 공개된 글이고, 그림 · 표 · 참고 문헌 표시를 뺀 본문을 실었습니다.
출처 Elwyn et al. (2016), Implementation Science : IS · 라이선스 CC BY 4.0 · 원문
이 장은 원문만 있습니다. 문장별 해석은 앞 장부터 차례로 붙입니다.
1장 · Implementing shared decision-making: consider all the consequences
색을 입힌 곳이 TOEFL® 읽기 문제에 실린 대목입니다. 그 앞뒤의 글을 이어 읽어 보세요. 대목으로 가기
Background: The ethical argument that shared decision-making is “the right” thing to do, however laudable, is unlikely to change how healthcare is organized, just as evidence alone will be an insufficient factor: practice change is governed by factors such as cost, profit margin, quality, and efficiency. It is helpful, therefore, when evaluating new approaches such as shared decision-making to conceptualize potential consequences in a way that is broad, long-term, and as relevant as possible to multiple stakeholders. Yet, so far, evaluation metrics for shared decision-making have been mostly focused on short-term outcomes, such as cognitive or affective consequences in patients. The goal of this article is to hypothesize a wider set of consequences, that apply over an extended time horizon, and include outcomes at interactional, team, organizational and system levels, and to call for future research to study these possible consequences.
Main argument: To date, many more studies have evaluated patient decision aids rather than other approaches to shared decision-making, and the outcomes measured have typically been focused on short-term cognitive and affective outcomes, for example knowledge and decisional conflict. From a clinicians perspective, the shared decision-making process could be viewed as either intrinsically rewarding and protective, or burdensome and impractical, yet studies have not focused on the impact on professionals, either positive or negative. At interactional levels, group, team, and microsystem, the potential long-term consequences could include the development of a culture where deliberation and collaboration are regarded as guiding principles, where patients are coached to assess the value of interventions, to trade-off benefits versus harms, and assess their burdens—in short, to new social norms in the clinical workplace. At organizational levels, consistent shared decision-making might boost patient experience evaluations and lead to fewer complaints and legal challenges. In the long-term, shared decision-making might lead to changes in resource utilization, perhaps to reductions in cost, and to modification of workforce composition. Despite the gradual shift to value-based payment, some organizations, motivated by continued income derived from achieving high volumes of procedures and contacts, will see this as a negative consequence.
Conclusion: We suggest that a broader conceptualization and measurement of shared decision-making would provide a more substantive evidence base to guide implementation. We outline a framework which illustrates a hypothesized set of proximal, distal, and distant consequences that might occur if collaboration and deliberation could be achieved routinely, proposing that well-informed preference-based patient decisions might lead to safer, more cost-effective healthcare, which in turn might result in reduced utilization rates and improved health outcomes.
Background
Shared decision-making is widely considered good in and of itself: healthcare professionals have a duty to inform people about the benefits and harms of proposed interventions. These duties are at the core of good clinical practice. Shared decision-making is defined by extending this duty to supporting people to arrive at informed preferences, eliciting and respecting those preferences by integrating them as decisions are made. Shared decision-making is distinguished from various models of patient-clinician communication, such as motivational interviewing, by being focused on choice rather than change. The process is described in more detail using the terms collaborative deliberation. We use the terms shared decision-making and collaborative deliberation interchangeably in this article. Shared decision-making does not advocate deliberation in every interaction or for every decision—that would be impractical. Rather, a deliberative approach is suggested where the existence of reasonable alternatives justify the work of informing patients so that they are able to form and share preferences about them.
It has been argued that shared decision-making represents the pinnacle of patient-centered care. Epstein’s summary of the evidence about the healing effect of good communication has reinforced the ethical imperative that practice should be based on collaboration and deliberation. Yet, despite these arguments and this evidence, shared decision-making is not widely adopted in routine clinical practice.
Powerful influences drive the practice of medicine, and so an ethics-based, deontological view, alone, does not lead to significant change in how healthcare is organized and delivered. Researchers respond by generating evidence to support a consequentialist viewpoint. Studies are typically designed to investigate how shared decision-making might improve short-term outcomes that are relevant to both patients and others. Accepting that neither ethical arguments, nor rational evidence, alone or in combination, are the only factors that predict change in clinical practice, we noticed limitations in how researchers have evaluated shared decision-making in published studies.
Evaluation metrics for shared decision-making have been focused on short-term outcomes, mostly assessing cognitive or affective effects on patients, with limited agreement about how to value, and in some cases even how to measure the desired outcomes. These short-term outcomes have consequences in the longer term, of course, leading to calls for healthcare delivery researchers to consider broader contexts over time, including interventions that simultaneously consider patients, clinical teams, organizations and systems in which they deliver care. These calls suggest the need to go beyond the evaluation of dyadic interactions to “include examination of mechanisms and measure of the effectiveness of healthcare organizations and health systems in improving outcomes”. Future evaluations might have more impact if they were able to measure consequences that are valued by a wider array of stakeholders: patients, clinicians, as well as organizational managers and executives, and policy makers.
At a time when the sustainability of healthcare delivery systems is questioned because of high costs and overzealous medicalization, it is possible that shared decision making might be an approach that gains wider acceptance. But existing efforts to study shared decision-making have mostly focused on how clinicians interact with patients, without paying attention to team, organizational, and system level factors in which these interactions are embedded. Existing work therefore has for the most part not provided evidence of sustained change in practice, nor have the tools that have been advocated become widely embedded into delivery systems. Despite the policy interest in shared decision-making, the majority of organizations and delivery systems of care delivery cite barriers and remain indifferent to whether shared decision-making is taking place, with or without patient decision aids.
Reflecting on the existing research on shared decision-making, we suggest that the work to date has had too narrow a focus, with insufficient agreement on the conceptualization of shared decision-making, as well as a conflation of two topics, a shared decision-making process and the use of patient decision aids.
Most definitions of shared decision-making call for high-quality information and the participation of patients in a process of decision-making. That much is uncontroversial. However, debate continues on several key issues that affect assessment of the quality of a shared decision-making process and how to value commonly measured short-term outcomes, e.g., the ideal role of patients in a decision-making process and decision conflict as an outcome, and whether current measures accurately capture the increased ambivalence that arises when options are recognized. Should the preferred role of a patient always be followed (rather than compel patients to engage in all decisions)? Insisting that patients engage in decision-making is the position described by the term mandatory autonomy. This approach does not receive wide support but some ethicists argue for it. Most advocates of shared decision-making take the view that patients should be engaged in decisions to the extent that they wish to do so—a position described by the term optional autonomy, as there is some evidence that doing so is helpful. Nevertheless, further research in this area is needed to clarify how patient participation, whether desired or not, affects health outcomes across settings. In terms of cognitive-affective outcomes, clarity about the ideal psychological pathway—from option recognition, to meaningful comparison, and the resolution of the inherent emotional work of choosing among alternatives, has not yet been fully elucidated. Clarity about expected proximal measures could help us. Different conceptualizations, measured differently, produce results that are difficult to compare. Meaningful debate of these and other questions requires competing hypotheses to be tested.
A second problem, and one which has been partly responsible for the narrow focus, is the conflation of a shared decision-making process and the use of patient decision aids. For a decade or more, there seemed to be a belief that tools designed to deliver information to patients could lead patients and clinicians to engage in a process of collaboration and deliberation. This belief was so prevalent that only one of the randomized trials of patient decision support conducted between 1990 and 2006 made an effort to study the interactional process in clinical encounters. In other studies of patient decision aids, patients reported being more involved in decisions but there was no confirmatory evidence from observational data. This changed when a research group at the Mayo Clinic began to use observer-based measures as well as patient-reported outcomes. It is worth noting that the tools under investigation in the Mayo trials were specifically designed to create collaborative conversations, so the data are not strictly comparable to studies of patient decision aids given to patients before clinical encounters. This conflation has delayed progress on research into the process of shared decision-making, viewed as a two-way communication. It has rather led to an emphasis on patient decision aids, to their development, evaluation, and to the development of quality “standards.” Insufficient work has been done testing the assumption that the use of these tools would lead to shared decision-making. At the same time, this conflation led to significant policy emphasis and legislative change. The Affordable Care Act in the USA supported shared decision-making; however, the wording of the law implies that it could be achieved by incentivizing the use of patient decision aids, and the development of a certification process to standardize the quality of these tools, when in fact, we have no evidence that tools on their own will achieve this goal.
Nevertheless, the results of over 100 trials of patient decision aids have been consistent. After exposure to the tools, patients’ knowledge increases, patients make more accurate assessments of risk, they report more involvement in decision-making, they do not become more anxious, and they report being more satisfied and more confident in their decisions. These, in broad terms, are the typical outcomes that have been measured—described by Shay and Lafata as cognitive-affective outcomes. These outcomes are typically measured soon after the relevant clinical interactions, testing the hypothesis that exposure to patient decision aids leads to positive effects on knowledge, satisfaction, and perceived involvement, without increasing regret or decisional conflict.
We suggest that this conceptualization of shared decision-making is too narrow; it fails to address the potential relationship between shared decision-making and a range of consequences that might occur over a longer span of time if healthcare professionals embraced the tasks of collaborating with patients to carefully consider the harms and benefits of potential alternatives.
We argue that it would be timely to consider a wider range of outcomes where collaborative deliberation has been achieved. To do so, we would assume that the research would be able to study settings where clinicians were both able and willing to accomplish shared decision-making or that both patients and clinicians were able to use patient decision support tools as required, or both. Such settings are difficult to achieve, given that space, resources, and context will be effect modifiers. Current healthcare settings, in the USA and elsewhere, have financial and other incentives that are not well-aligned to support collaboration and deliberation with patients about alternative options, although these are changing with growing emphasis on value-based payment methods. We recognize of course that achieving ideal conditions for shared decision-making to have its greatest impact is not easy, but for the purposes of developing a hypothetical framework—such an assumption allows us to focus on consequences rather than worry here about the fidelity to shared decision-making.
The aim of this article is to analyze the work done in this area and to propose a conceptual framework that hypothesizes the impact of collaborative deliberation at individual, interactional, organization, and system levels. We describe opportunities to examine these consequences and the possibility of evaluating causal pathways.
TOEFL® 읽기 문제 5문항. 이 장의 한 대목을 그대로 옮기고 문항을 붙였습니다. 대목을 읽고 문제를 풉니다.
이 글은 위 출처의 원문을 그 라이선스(CC BY 4.0)에 따라 옮겼습니다. 참고문헌 목록과 인용 번호, 그림 · 표 · 각주 · 수식 · 부록은 빼고 절별로 나누어 실었으며, 그 밖의 문장은 원문 그대로입니다. 원 저작자와 발행 기관은 이 화면을 만들거나 검토하지 않았고, 이곳의 해석과 낱말 풀이는 공식 번역이 아닙니다.
